Zepbound KwikPen (Tirzepatide) Injection – Prescription Medication

Zepbound KwikPen (Tirzepatide) Injection

Zepbound KwikPen is a prescription medication containing tirzepatide. In Canada, Zepbound KwikPen is authorized as a multi-dose prefilled pen for subcutaneous administration and is available in six strengths: 2.5 mg/0.6 mL, 5 mg/0.6 mL, 7.5 mg/0.6 mL, 10 mg/0.6 mL, 12.5 mg/0.6 mL and 15 mg/0.6 mL. Health Canada identifies Zepbound as a prescription product.

Active Ingredient

The medicinal ingredient in Zepbound KwikPen is tirzepatide. It belongs to a class of medicines that acts on GIP and GLP-1 receptors. The Canadian product monograph describes Zepbound as an obesity-management medication.

Available Strengths

Zepbound KwikPen is available in:

• 2.5 mg/0.6 mL
• 5 mg/0.6 mL
• 7.5 mg/0.6 mL
• 10 mg/0.6 mL
• 12.5 mg/0.6 mL
• 15 mg/0.6 mL

Each multi-dose pen contains four doses.

How It Is Supplied

Zepbound KwikPen is supplied as a prefilled injection pen intended for subcutaneous use. The appropriate strength and dosing schedule should be determined by a healthcare professional based on the patient’s medical circumstances and the approved product information.

Do not select or change your Zepbound dose based solely on information found online. Follow the instructions provided by your prescriber and the Canadian product monograph.

Prescription Medication

Zepbound KwikPen is a prescription medication in Canada. A valid prescription and appropriate professional oversight are required.

Before using tirzepatide, patients should discuss their medical history, current medicines, allergies and other relevant health information with their healthcare professional.

Important Safety Information

Do not use Zepbound KwikPen if you have a known allergy to tirzepatide or any of its ingredients, or in situations where the Canadian product information advises against its use.

The Canadian patient information also identifies important precautions involving certain thyroid conditions, pregnancy and breastfeeding. Patients should review the complete product information and speak with their healthcare professional before starting treatment.

Possible adverse effects and other safety considerations should be discussed with a healthcare professional. Seek medical attention for serious or unexpected symptoms.

Storage and Handling

Store and handle Zepbound KwikPen according to the conditions specified in the current Canadian product monograph and the instructions supplied with the product. Do not use a pen that has been improperly stored, damaged or otherwise compromised.

CanadaPharmaStore

CanadaPharmaStore provides product information to help Canadian customers understand prescription medications and their available presentations.

Prescription required. Healthcare professional consultation recommended.

This webpage is for informational purposes and does not replace medical advice, diagnosis or treatment. Always use prescription medicines exactly as directed by your healthcare professional and according to the official Canadian product information.